Peter ten Dijke

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Weixin Liao · 1 shared paper, 2026 · strength 0.32
   • Paper Tumor-intrinsic Ist1 restricts IFNγ responsiveness to drive immune evasion in pancreatic cancer DOI 10.21203/rs.3.rs-10348019/v1↗
2. Jing Zhang · 2 shared papers, 2020–2022 · strength 0.28
   • Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
   • Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
3. Manfred Wuhrer · 2 shared papers, 2020–2022 · strength 0.28
   • Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
   • Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
4. Tao Zhang · 2 shared papers, 2020–2022 · strength 0.28
   • Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
   • Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
5. Yuanzhuo Gu · 1 shared paper, 2023 · strength 0.22
   • Paper Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreat… DOI 10.1126/sciadv.adf9915↗
6. Stephanie Holst · 1 shared paper, 2022 · strength 0.16
   • Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
7. Marten Hornsveld · 1 shared paper, 2022 · strength 0.13
   • Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019↗
8. Tom J. Harryvan · 1 shared paper, 2022 · strength 0.13
   • Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019↗
9. Lukas J.A.C. Hawinkels · 1 shared paper, 2022 · strength 0.13
   • Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019↗
10. Carina Strell · 1 shared paper, 2022 · strength 0.13
    • Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019↗
11. Jeanin Elise van Hooft · 1 shared paper, 2022 · strength 0.13
    • Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019↗
12. Arne Östman · 1 shared paper, 2022 · strength 0.13
    • Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019↗
13. Ana I. Belo · 1 shared paper, 2020 · strength 0.11
    • Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
14. Irma van Die · 1 shared paper, 2020 · strength 0.11
    • Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.